Every year, insurance plans update the list of drugs that they cover, also known as their formulary. That means that some drugs covered this year won’t be covered next year. (In fact, more and more drugs are excluded from formularies each year.) And drugs that are new to the market might be covered soon. If you rely on health insurance to pay for your medications, now’s a good time to pay attention. See More
Morphine and Naltrexone Latest News
Get the latest updates on this drug from the GoodRx medical team
In response to the current opioid epidemic, the FDA has been encouraging drug companies to create abuse-deterrent pain medications. These medications have properties that make it harder, or less rewarding, for a person to inject or snort them, and are typically resistant to crush or extraction. Some abuse-deterrent pain medications that you may have heard of include Xtampza ER (oxycodone) and Hysingla ER (hydrocodone), and now we have another to add to the list! The FDA recently approved Arymo ER (morphine), an extended-release tablet for the treatment of pain, and it is now available in pharmacies. See More
Embeda is a schedule II extended-release narcotic used for the management of severe pain that requires daily, around-the-clock treatment on a long-term basis. It contains extended-release morphine as well as the abuse deterrent naltrexone.
The new formulation of Embeda has properties that are expected to reduce, but not totally prevent, abuse of the medication. Naltrexone is thought to prevent the euphoric effect of the medication if it is crushed, chewed, or dissolved for snorting or injecting. See More